Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


01.05.2017

1 Ann Neurol
1 Brain
1 J Neurol Neurosurg Psychiatry
2 J Neurol Sci
1 Lancet Neurol
2 Mult Scler
7 N Engl J Med
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. ANDRODIAS G, Bernard E, Biotti D, Collongues N, et al
    Multiple sclerosis broke my heart.
    Ann Neurol. 2017 Apr 24. doi: 10.1002/ana.24935.
    PubMed     Text format     Abstract available


    Brain

  2. EL BEHI M, Sanson C, Bachelin C, Guillot-Noel L, et al
    Adaptive human immunity drives remyelination in a mouse model of demyelination.
    Brain. 2017;140:967-980.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  3. OKADA K, Kobata M, Sennari Y, Iwanaka Y, et al
    Levels of nitric oxide metabolites in cerebrospinal fluid correlate with cognitive impairment in early stage multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Apr 26. pii: jnnp-2017-315585.
    PubMed     Text format    


    J Neurol Sci

  4. HEESEN C, Kleiter I, Meuth SG, Kramer J, et al
    Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients.
    J Neurol Sci. 2017;376:181-190.
    PubMed     Text format     Abstract available

  5. JORGENSEN M, Dalgas U, Wens I, Hvid LG, et al
    Muscle strength and power in persons with multiple sclerosis - A systematic review and meta-analysis.
    J Neurol Sci. 2017;376:225-241.
    PubMed     Text format     Abstract available


    Lancet Neurol

  6. WIJNANDS JMA, Kingwell E, Zhu F, Zhao Y, et al
    Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study.
    Lancet Neurol. 2017 Apr 20. pii: S1474-4422(17)30076.
    PubMed     Text format     Abstract available


    Mult Scler

  7. TOUSSAINT-DUYSTER LC, Wong YYM, Van der Cammen-van Zijp MH, Van Pelt-Gravesteijn D, et al
    Fatigue and physical functioning in children with multiple sclerosis and acute disseminated encephalomyelitis.
    Mult Scler. 2017 Apr 1:1352458517706038. doi: 10.1177/1352458517706038.
    PubMed     Text format     Abstract available

  8. HAGENS MH, Killestein J, Yaqub MM, van Dongen GA, et al
    Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study.
    Mult Scler. 2017 Apr 1:1352458517704507. doi: 10.1177/1352458517704507.
    PubMed     Text format     Abstract available


    N Engl J Med

  9. HAUSER SL, Belachew Sh, Kappos L
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed     Text format    

  10. SCHOERGENHOFER C, Jilma B
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693.
    PubMed     Text format    

  11. MONTALBAN X, Belachew S, Wolinsky JS
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    PubMed     Text format    

  12. KORN T, Oukka M
    A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
    N Engl J Med. 2017;376:1680-1681.
    PubMed     Text format    

  13. SHARP MK
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692.
    PubMed     Text format    

  14. MILDINER S, Malnick S
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692-3.
    PubMed     Text format    

  15. DEISENHAMMER F, Auer M, Hegen H
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693-4.
    PubMed     Text format    


    PLoS One

  16. SCHNEIDER R, Bellenberg B, Hoepner R, Kolb EM, et al
    Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    PLoS One. 2017;12:e0176415.
    PubMed     Text format     Abstract available

  17. INGLESE M, Petracca M, Mormina E, Achiron A, et al
    Cerebellar volume as imaging outcome in progressive multiple sclerosis.
    PLoS One. 2017;12:e0176519.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  18. ROGERS JA, Mishra MK, Hahn J, Greene CJ, et al
    Gestational bisphenol-A exposure lowers the threshold for autoimmunity in a model of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2017 Apr 24. pii: 201620774.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: